Hormone Therapy in Children and Adolescents.
Gender-affirming hormones
GnRH analogs
Pubertal suppression
Transgender youth
Journal
Endocrinology and metabolism clinics of North America
ISSN: 1558-4410
Titre abrégé: Endocrinol Metab Clin North Am
Pays: United States
ID NLM: 8800104
Informations de publication
Date de publication:
06 2019
06 2019
Historique:
entrez:
28
4
2019
pubmed:
28
4
2019
medline:
1
2
2020
Statut:
ppublish
Résumé
For children and adolescents with gender dysphoria, an interdisciplinary care team is essential for proper diagnosis and appropriate treatment. For children who present with gender dysphoria, once puberty begins, they can be treated with gonadotropin-releasing hormone analogs to stop pubertal progression. This allows for further gender exploration, relief of dysphoria, and better cosmetic outcomes by avoiding the physical changes associated with puberty of the gender assigned at birth. After pubertal suppression, the individual may opt to proceed with puberty or start treatment with gender-affirming hormones.
Identifiants
pubmed: 31027543
pii: S0889-8529(19)30003-9
doi: 10.1016/j.ecl.2019.01.003
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
331-339Informations de copyright
Copyright © 2019 Elsevier Inc. All rights reserved.